K M Little1, M Khundi2, G L Barnes3, L G Ngwira2, A Nkhoma2, S Makombe4, E L Corbett5, R E Chaisson3, D W Dowdy1. 1. Epidemiology Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 2. Malawi Liverpool Wellcome Trust, Blantyre, Malawi. 3. Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. 4. Ministry of Health, Malawi, Lilongwe, Malawi. 5. Malawi Liverpool Wellcome Trust, Blantyre, Malawi, Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.
Abstract
SETTING: To reduce the risk of tuberculosis (TB) among individuals with human immunodeficiency virus (HIV) infection, the World Health Organization recommends at least 6 months of isoniazid preventive therapy (IPT). Completion of IPT remains a major challenge in resource-limited settings. OBJECTIVE: To evaluate predictors of IPT completion in individuals newly diagnosed with HIV. DESIGN: Predictors of IPT completion among adults newly diagnosed with HIV in rural Malawi were evaluated using a multilevel logistic regression model. RESULTS: Of 974 participants who screened negative for active TB and were started on IPT, 732 (75%) completed treatment. Only one IPT-eligible individual refused treatment. Participants who were aged <25 years (compared with those aged 45 years, adjusted OR [aOR] 0.33, 95%CI 0.18-0.60) and male (compared to non-pregnant females, aOR 0.57, 95%CI 0.37-0.88) had lower odds of IPT completion. CONCLUSION:IPT provision at the time of initial HIV diagnosis was highly acceptable in rural Malawi; three quarters of those who initiated IPT successfully completed therapy. We observed lower odds of completion among males and among female participants aged <25 years. Additional efforts may be needed to ensure IPT completion among males and young females who have recently been diagnosed with HIV.
RCT Entities:
SETTING: To reduce the risk of tuberculosis (TB) among individuals with human immunodeficiency virus (HIV) infection, the World Health Organization recommends at least 6 months of isoniazid preventive therapy (IPT). Completion of IPT remains a major challenge in resource-limited settings. OBJECTIVE: To evaluate predictors of IPT completion in individuals newly diagnosed with HIV. DESIGN: Predictors of IPT completion among adults newly diagnosed with HIV in rural Malawi were evaluated using a multilevel logistic regression model. RESULTS: Of 974 participants who screened negative for active TB and were started on IPT, 732 (75%) completed treatment. Only one IPT-eligible individual refused treatment. Participants who were aged <25 years (compared with those aged 45 years, adjusted OR [aOR] 0.33, 95%CI 0.18-0.60) and male (compared to non-pregnant females, aOR 0.57, 95%CI 0.37-0.88) had lower odds of IPT completion. CONCLUSION:IPT provision at the time of initial HIV diagnosis was highly acceptable in rural Malawi; three quarters of those who initiated IPT successfully completed therapy. We observed lower odds of completion among males and among female participants aged <25 years. Additional efforts may be needed to ensure IPT completion among males and young females who have recently been diagnosed with HIV.
Authors: Khai Hoan Tram; Florence Mwangwa; Gabriel Chamie; Mucunguzi Atukunda; Asiphas Owaraganise; James Ayieko; Vivek Jain; Tamara D Clark; Dalsone Kwarisiima; Maya L Petersen; Moses R Kamya; Edwin D Charlebois; Diane V Havlir; Carina Marquez Journal: AIDS Care Date: 2019-06-10
Authors: Mahendra M Reddy; Pruthu Thekkur; Nagesh Ramya; Prasanna B T Kamath; Suresh G Shastri; Ravi B N Kumar; Palanivel Chinnakali; Abhay S Nirgude; Chethana Rangaraju; Narasimhaiah Somashekar; Ajay M V Kumar Journal: Glob Health Action Date: 2020 Impact factor: 2.640
Authors: Muthoni Karanja; Leonard Kingwara; Philip Owiti; Elvis Kirui; Faith Ngari; Richard Kiplimo; Maurice Maina; Enos Masini; Elizabeth Onyango; Catherine Ngugi Journal: PLoS One Date: 2020-12-02 Impact factor: 3.240
Authors: Scott A Nabity; Laurence J Gunde; Diya Surie; Ray W Shiraishi; Hannah L Kirking; Alice Maida; Andrew F Auld; Michael Odo; Andreas Jahn; Rose K Nyirenda; John E Oeltmann Journal: PLoS One Date: 2021-04-01 Impact factor: 3.240
Authors: Lufina Tsirizani-Galileya; Elasma Milanzi; Randy Mungwira; Titus Divala; Jane Mallewa; Donnie Mategula; Nginache Nampota; Victor Mwapasa; Andrea Buchwald; Matthew B Laurens; Miriam K Laufer; Joep J Van Oosterhout Journal: Medicine (Baltimore) Date: 2022-09-30 Impact factor: 1.817